BenzingaSeptember 9, 2026 at 3:22 AM NYLast Month
BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $56
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $60 to $56.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
